Ac-Ala-Ala-OMe
|
|
30802-26-7
|
Ac-Ala-Ala-Ala-OH
|
|
19245-85-3
|
Ac-Ala-Ala-Ala-OMe
|
|
26910-17-8
|
Ac-Ala-Ala-Ala-Ala-OH
|
|
15483-58-6
|
Ac-Ala-Ala-Ala-Ala-OMe
|
|
30802-29-0
|
Acetyl-Neurotrophin Receptor (368-381) amide (human)
|
|
197230-90-3
|
Ac-Gln-Gln-OH
|
|
69624-04-0
|
Ac-Gly-Ala-Val-Ile-Leu-Arg-Arg-NH2
|
|
1092658-86-0
|
(d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin
|
|
73168-24-8
|
(Deamino-Cys1,D-Arg8)-Vasopressin
|
|
16679-58-6
|
(Deamino-Cys1,β-cyclohexyl-Ala4,Arg8)-Vasopressin
|
|
500170-27-4
|
(Deamino-Cys1,Leu4,Lys8)-Vasopressin
|
|
42061-33-6
|
(Deamino-Cys1,Lys8)-Vasopressin
|
|
2989-84-6
|
(Deamino-Cys1,D-Orn8)-Vasopressin
|
|
60498-04-6
|
(Deamino-Cys1,β-(3-pyridyl)-D-Ala2,Arg8)-Vasopressin
|
|
136105-89-0
|
(Deamino-Cys1,Val4,D-Arg8)-Vasopressin
|
|
43157-23-9
|
(Deamino-Pen1,Tyr(Me)2, Arg8)-Vasopressin
|
|
67269-08-3
|
(Deamino-Pen1,Val4,D-Arg8)-Vasopressin
|
|
64158-84-5
|
(3,5-Diiodo-Tyr2,Arg8)-Vasopressin
|
|
63441-67-8
|
(Lys8)-Vasopressin
|
|
50-57-7
|
TLQP-21 (human)
|
|
1259837-37-0
|
TLQP-21 (mouse, rat)
|
|
869988-94-3
|
PHI-27 (porcine)
|
|
80458-29-3
|
PHI-27 (rat)
|
|
96849-38-6
|
PHM-27 (human)
|
|
87403-73-4
|
Prepro VIP (156-170) (human)
|
|
107902-86-3
|
VIP (guinea pig)
|
|
96886-24-7
|
VIP (human, mouse, rat)
|
|
40077-57-4
|
Gly-Neuroendocrine Regulatory Peptide-3 (human, mouse, rat)
|
|
1815618-19-9
|
Neuroendocrine Regulatory Peptide-4 (human, mouse, rat)
|
|
922704-18-5
|
Sarafotoxin C
|
|
121695-87-2
|
(Lys4)-Sarafotoxin C
|
|
1219444-22-0
|
Stichodactyla helianthus Neurotoxin (ShK)
|
|
172450-46-3
|
(Dap22)-Stichodactyla helianthus Neurotoxin (ShK)
|
|
220384-25-8
|
6-FAM-AEEAc-Stichodactyla helianthus Neurotoxin (ShK)
|
|
1927927-42-1
|
Tertiapin
|
|
58694-52-3
|
Tertiapin-Q
|
|
910044-56-3
|
Toxin GaTx1
|
|
1926163-15-6
|
H-p-Chloro-Phe-D-Cys-β-(3-pyridyl)-Ala-D-Trp-Lys-Val-Cys-p-chloro-Phe-NH2 (Disulfide bond)
|
|
209006-05-3
|
Urotensin I
|
|
83930-33-0
|
Urotensin II (goby)
|
|
9047-55-6
|
Urotensin II (human)
|
|
251293-28-4
|
(Pen5)-Urotensin II (4-11) (human)
|
|
473902-31-7
|
(Pyr1)-Urotensin II (rat)
|
|
405136-99-4
|
Urotensin II-Related Peptide (human, mouse, rat)
|
|
342878-90-4
|
Copeptin (human)
|
|
78362-34-2
|
Copeptin (rat)
|
|
86280-64-0
|
Boc-Pressinoic acid
|
|
72287-67-3
|
Terlipressin
|
|
14636-12-5
|
(1-Adamantaneacetyl1,D-Tyr(Et)2,Val4,Abu6, Arg8.9)-Vasopressin
|
|
112465-00-6
|
(Phenylac1,D-Tyr(Et)2,Lys6,Arg8,des-Gly9)-Vasopressin
|
|
129520-65-6
|
(Phenylac1,D-Tyr(Me)2,Arg6·8,Lys-NH29)-Vasopressin
|
|
148565-73-5
|
(Phenylac1,D-Tyr(Me)2,Arg6·8,Tyr-NH29)-Vasopressin
|
|
135447-36-8
|
(Propionyl1,D-Tyr(Et)2,Val4,Abu6,Arg8·9)-Vasopressin
|
|
121250-95-1
|
(Arg8)-Vasopressin (4-9)
|
|
96027-30-4
|
AQEE-30 (human)
|
|
160046-70-8
|
AQEE-30 (mouse, rat)
|
|
323185-80-4
|
LQEQ-19 (mouse, rat)
|
|
322644-72-4
|
Neuroendocrine Regulatory Peptide-1 (human)
|
|
954420-50-9
|
Neuroendocrine Regulatory Peptide-1 (rat)
|
|
954420-51-0
|
Neuroendocrine Regulatory Peptide-2 (human)
|
|
1872441-23-0
|
Neuroendocrine Regulatory Peptide-2 (rat)
|
|
1872441-24-1
|
(Arg8)-Vasopressin
|
|
113-79-1
|
Biotinyl-(Arg8)-Vasopressin
|
|
126703-17-1
|
(Arg8)-Vasopressin (free acid)
|
|
25255-33-8
|
(Arg8,des-Gly-NH29)-Vasopressin
|
|
37552-33-3
|
(3-(4-Azidophenyl)propionyl1,D-Tyr(Me)2,Arg6,Arg8,Tyr-NH29)-Vasopressin
|
|
157702-46-0
|
(d(CH2)51,D-Ile2,Ile4,Arg8)-Vasopressin
|
|
88686-53-7
|
(d(CH2)51,D-Ile2,Ile4,Arg8,Ala-NH29)-Vasopressin
|
|
114455-29-7
|
(d(CH2)51,D-Phe2,Ile4,Ala-NH29)-Vasopressin
|
|
99835-78-6
|
(d(CH2)51,Tyr(Et)2,Val4,Arg8,des-Gly-NH29)-Vasopressin
|
|
110567-67-4
|
(d(CH2)51,D-Tyr(Et)2,Val4,Arg8,des-Gly9)-Vasopressin
|
|
90332-82-4
|
(d(CH2)51,Tyr(Et)2,Val4,Arg8,des-Gly9)-Vasopressin
|
|
90332-81-3
|
(Ala11·22·28)-VIP (human, mouse, rat)
|
|
291524-04-4
|
(β-Asp3)-VIP (human, mouse, rat)
|
|
1926163-85-0
|
Biotinyl-VIP (human, mouse, rat)
|
|
1815618-13-3
|
(p-Chloro-D-Phe6,Leu17)-VIP (human, mouse, rat)
|
|
102805-45-8
|
Hexanoyl-(Ala19,Lys27.28)-VIP (free acid)
|
|
1926163-31-6
|
(D-Phe2)-VIP (human, mouse, rat)
|
|
104051-15-2
|
Myristoyl-(Lys12.27.28)-VIP-Gly-Gly-Thr (free acid)
|
|
|
VIP sulfoxide (human, mouse, rat)
|
|
95050-90-1
|
(Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27)
|
|
201995-58-6
|
Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27)
|
|
202463-00-1
|
VIP (3-28) (human, mouse, rat)
|
|
115444-33-2
|
VIP (4-28) (human, mouse, rat)
|
|
64326-02-9
|
VIP (6-28) (human, mouse, rat)
|
|
69698-54-0
|
(Pyr16)-VIP (16-28) (human, mouse, rat)
|
|
134907-86-1
|
VIP Antagonist
|
|
125093-93-8
|
VIP Receptor-Binding Inhibitor L-8-K
|
|
120550-85-8
|
Ac-Met-Asp-Lys-Val-Leu-Asn-Arg-Glu-OH
|
|
287193-38-8
|
H-Ala-Lys-Leu-Arg-Glu-Arg-Leu-Lys-Gln-Arg-Gln-Gln-Leu-Gln-Asn-Arg-Arg-Gly-Leu-Asp-Ile-Leu-Phe-Leu-Gln-Glu-Gly-Gly-Leu-OH
|
|
126947-95-3
|
HHV-2 Envelope Glycoprotein G (552-574)
|
|
2022956-63-2
|
FITC-εAhx-HHV-2 Envelope Glycoprotein G (561-578)
|
|
2022956-64-3
|
HSV-1 Glycoprotein (gB) (497-507)
|
|
148337-11-5
|
HTLV-1 Tax (11-19)
|
|
141677-18-1
|
Influenza PR8 Hemagglutinin Peptide (110-119)
|
|
132031-50-6
|
Matrix Protein M1 (58-66) (Influenza A virus)
|
|
141368-69-6
|
Pre-S2 (1-26)
|
|
104753-45-9
|
Vesicular Stomatitis Virus Nucleoprotein (52-59)
|
|
132326-74-0
|
Ac-Ala-Ala-OH
|
|
19245-87-5
|